and europe and the uk were criticised for moving too quickly but i think most people would say the nhra of other european countries although the us and certainly germany have begun to move more quickly as well. we were hearing on friday that the us is expecting the uk variant as it is known to become the dominant strain there by march. we are hearing about a brazil variant, your lockdown, beginning on monday in terms of travel access to the uk people having to have a test or isolating. how much confidence as they are that the vaccine so far developed can deal with that? scientists say as of now there is no evidence that any of these variants will be resistant to the vaccine but they have got to keep monitoring it. the situation is moving so quickly. with brazil, there are two variants, one is in the uk but thought not to be particularly problematic and then another one which is much more so which has appeared in japan. the uk variant, which is known as the kent variant from the south—east of england, was moving very fast in december but the figures for the uk suggest cases may be coming

last month, the uk's nhra became the first regulator in the world to approve the oxford astrazeneca jab agency is meeting and is expected to approve the vaccine. but for the moment, it vaccine. but forthe moment, it remains vaccine. but for the moment, it remains unlicensed in that you. i'm joined now by david herszenhorn — chief brussels correspondent for politico. david, thank for being with us on outside source. we heard that the president of the european council was pursuing all avenues available. can you help us understand what options that you house?- can you help us understand what options that you house? well, they are t in: options that you house? well, they are trying to _ options that you house? well, they are trying to reserve _ options that you house? well, they are trying to reserve all— options that you house? well, they are trying to reserve all options - options that you house? well, they are trying to reserve all options at. are trying to reserve all options at this point. obviously, tensions are running very, very high. as you heard the european commission today has d

with the scientist over the last days, weeks and intensively in the last few hours and i'm confident nhra will be in a position to turn around new applications for new variants of vaccines and may be required of the virus. >> thank you very much mr. speaker sitting idle today is a stark reminder that post brexit written can be self-sufficient through infrastructure investments is crucial, because the prime minister provide the infrastructure of investment essential by giving the environment agency and funding to keep it operational and to maintain the watercourses, this will be vital to ensure the rich producing land essential for food supply and our local and national economy as well as protect -- prime minister. >> the producing an entirely and we will protect and she is entirely right that's why we put five-point to billion into flood defense including the pumping station which the honorable lady mentions and we have invested which is 5.7 million pounds to protect the 4000 pounds. >> thank you, mr. speaker the southwest has an ambitious program to build back better in both the green an

relatively pretty well and that is partly down to our largely down to the regular tory system, the nhra lockdown beginning on monday in terms of travel access to the uk people having to have a test on isolating. how much confidence as they are that the vaccine so far developed can deal with that? scientists say as of now there is no evidence that any of these variants will be desisted to the vaccine but they have got to keep monitoring it. the situation is moving so quickly. with brazil there are two variants, one is in the uk but thought not to be particularly problematic and then another one which is much more so which has appeared injapan. the uk which has appeared injapan. the uk which is known as the kent variant from the south—east of england was moving very fast in december but the figures for the uk suggest cases may be coming down off the peak since it has been tackled effectively by long—term measures. this issue of variance as a very big potential problem longer term but i think for vaccines not at the moment. donald trump began his four years in the white house by having his

showpiece in the northern california region where you think the focus will be on the obviously nascar nhra but another signature event or do you look out for nothing's out of out of bounds. i don't think so if it makes sense to bring another signature event then we want to pursue that if it makes sense to create more. >>experience is driving schools, bring corporate hospitality. that makes sense i think we're going to have the ability really gauge the interest level of the marketplace ball community and that those that visit and determine what some rights schedule of events or are things that we need to offer i mean that's a beautiful facility. we want as many people to experience it and love it. as much as we do anything that's going to be double. >>coming up here next how to make sure your student is maintaining a well-round >>well as we deal with another semester of distance learning it's important for parents and students to come up with a routine that make sure they enough time away from their screens. natalie clydesdale spoke to pediatrician for some advice and the best way to approa

showpiece in the northern california region where do you think the focus will be on the obviously nascar nhra but do you have another signature bin or the lookouts for nothing's out of out of bounds. i don't think so if it makes sense to bring another signature event. >>then we want to pursue that if it makes sense to create more experience is driving schools, bring corporate hospitality. that makes sense i think we're going to have the ability really gauge the interest level of the marketplace ball community and that those that visit. >>and determine what some rights schedule of events or are things that we need to offer i mean that's a beautiful facility. we want as many people to experience it and love it. as much as we do anything that's going to be double. >>and that was on market demsky reporting nascar's sonoma this year's set for the weekend of june 6. >>4 sports brought to you by xfinity. >>on to the next one for the golden state warriors today, the dubs trying to move on after a tough loss to the clippers. and what must have been a mentally taxing night to several player shared thei

-made vaccine approved by the nhra that will be helpful to millions in this country and around the country. mr. speaker i move that the bill , be read a second time. and having taken back control of our money, our borders, our laws , and our waters by leaving the european union on january 31, we now seize this moment to forge a fantastic new relationship with , our european neighbors based on free-trade and friendly cooperation. in a minute, mr. speaker. at the heart of this bill is one of the biggest free-trade agreements in the world. a comprehensive -- a comprehensive -- i will be happy -- >> mr. speaker, seeking your clarification, i'm just wondering if the prime minister can talk about taking back control of waters, with scottish fishermen who are going to have less fish to catch as a consequence of this deal. >> we are very limited -- can we try to keep to a tight agenda to allow everybody the time to contribute? prime minister? prime minister johnson: mr. speaker, i must nonetheless correct, as that was not a valid i must correct him on what he point. said. under this deal, we have

, it was 30th of december, i think, the day that the oxford ask the zeneca vaccine approval by the nhra available. the reason and the justification is really clear and straightforward, which is that it says no lies. and ultimately, that is the public health justification, ultimately, that is the public healthjustification, and ultimately, that is the public health justification, and i ultimately, that is the public healthjustification, and i think it is why there is so much buy into this approach. the data show that there is a significant protection from both the oxford and the pfizer jabs. after the first dose. once you know that is true, given that we have a... given we have as much supply as we have coming into the country, and being manufactured in the country, of the toe doses, you wa nt to the country, of the toe doses, you want to use that as effectively as possible to save lives. so it is up public health justification. —— possible to save lives. so it is up public healthjustification. —— of the two doses. i think we all understand it have been through it enoughin understand it

the nhra and other regulators around the world will decide whether a single dose can be used.n the uk is important because it could be that the second dose will provide even higher and longer protection. and we know that because for many vaccines and diseases, prospectuses is better than one. the first stage just primes the immune systems —— two doses. and the booster dose can provide even more protection and memory response over a long period of time. and protection and memory response over a long period of time.— a long period of time. and is there a long period of time. and is there a timeframe _ a long period of time. and is there a timeframe between _ a long period of time. and is there a timeframe between the - a long period of time. and is there a timeframe between the two? - a long period of time. and is there a timeframe between the two? so | a long period of time. and is there - a timeframe between the two? so the janssen a timeframe between the two? so the janssen study — a timeframe between the two? so the janssen study is _ a timeframe between the two? so the jans

the regulator the nhra has been doing a rolling review of their data so far, but i think what we needm for a few months yet. in fact, not be on stream for a few months yet. infact, most likely, it will be the yet. in fact, most likely, it will be the vaccine that the younger people get, which will come on stream may be in a big way assuming, and we should not really assume, that it and we should not really assume, thatitis and we should not really assume, that it is approved, probably in the second half of the year. meanwhile, the wrangling over the oxford astrazeneca— the wrangling over the oxford astrazene . ., . . . ., , astrazeneca vaccine continues with the eumpean _ astrazeneca vaccine continues with the european union _ astrazeneca vaccine continues with the european union and _ astrazeneca vaccine continues with the european union and also - astrazeneca vaccine continues with i the european union and also germany casting doubt on whether it is really that effective for people over 65. why is their view so different from the uk? n over 65. why is their view so different from th

you work for the nhra which approve this vaccines.ou roll it out? the a three month delay crucial to how you roll it out?— a three month delay crucial to how you roll it out? the problem is, you don't have — you roll it out? the problem is, you don't have all— you roll it out? the problem is, you don't have all of— you roll it out? the problem is, you don't have all of the _ you roll it out? the problem is, you don't have all of the ingredients - you roll it out? the problem is, you don't have all of the ingredients to l don't have all of the ingredients to a vaccine necessary, or available on the tap, instantly. and you have to buy ahead and just issue you would in building a car or a house, you have to make sure all the material components are ordered well ahead of when you need to deliver it. if there is some uncertainty with the order and as you can see from astrazeneca plus possible point of view there wasn't certainty, where the eu would buy any vaccines in the end if they did not authorise the faxing, one would understand that

nhra, the drug regulation body, managed to get the current vaccines through the regulatory system very that, but you know other countries are getting there as well. and the roll—out is happening and beginning to happen around the world. there are many questions to be asked. for example, what are we doing about helping developing countries? if this disease goes on festering in our poorer parts of the community, in the inner cities, for example, and we are not seeing enough help going into those areas, and if it keeps building up in developing countries, it will come backin developing countries, it will come back ina developing countries, it will come back in a second or third wave of new forms of the virus. this new form of the virus we have in the uk is the reason why it is spreading so rapidly. it's over 50% faster in spreading than the other virus was, which is why this one has taken over. we can't expect this to be the last mutation of this coronavirus. it has got to be mutating again, and the next four may be even more deadly than this one. and it may not be dealt with by the vacci

showpiece in the northern california region where do you think the focus will be on the obviously nascar nhrather signature event or do you look out for nothing's out of out of bounds. i don't think so if it makes sense to bring another signature event then we want to pursue that if it makes sense to create more. >>experience is driving schools, bring corporate hospitality. that makes sense i think we're going to have the ability really gauge the interest level of the marketplace ball community and that those that visit. >>and determine what some rights schedule of events or are things that we need to offer i mean that's a beautiful facility. we want as many people to experience it and love it. as much as we do anything that's going to be double. >>and we're going to stay in sonoma county is leaders there are dealing with a surge in covid cases we'll take a look at the steps the county is now taking to stay prepared. that's coming up next on the kron 00:00am morning news, stay with us we'll be right back. ♪ don't just do it yourself. yes! do it for yourself. ♪ >>and 29 this sunday morning and

the nhra, the regulator, has been doing a rolling review of their data so far, but i think what we needs not going to be on stream for a few months yet. in fact, most likely, it will be the vaccine that the younger people get, that will come on stream in a big way, assuming... we should not really assume, that it is approved, probably in the second half of the year. 0ur europe correspondent gavin lee has the latest on the vaccine row between the eu and astrazeneca. a few days ago, the boss of astrazeneca did at one interview with the italian newspaper la repubblica, in which he said they have had bad luck, with their facilities in belgium, and also in the netherlands, which he said was for the eu and uk manufacturing sites for the vaccine, which would supply the uk first. he also said it was a contract with a clause that always said, we will deliver based on best efforts. today, speaking on german radio, commission president ursula von der leyen said it is crystal clear that thatis leyen said it is crystal clear that that is not the case. the clause on best efforts was only ever if you

older people, but there is a lot of data, and the scientists at the british equivalent and at the nhra ok, that's interesting, isn't it, in terms| a german vaccine. ok, that's l interesting, isn't it, in terms of politics, i suppose? meanwhile, fergus, there's been some concern about the pace of the vaccine roll—out in recent days. let's take a look at the latest figures. 282,812 people received their first dose in the latest 24—hour period, taking the overall number of people who've had theirfirstjab to more than 7.4 million. in order to hit the government's target of offering vaccines to 15 million by mid—february, around 380,000 vaccines need to be administered each day. fergus, are we still on track? it is going to be tight. there has been a bit of a slowdown in the last few days, but that must be down to suoply. few days, but that must be down to supply, because the supply is tight, but it will. .. supply, because the supply is tight, but it will... more doses will start being released at the beginning of february, and there was one day when almost half a million people, about alm